vertigo-type dizziness; slight headache; vertigo-type dizziness; This is a spontaneous report from a contactable consumer (patient). A 77-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: EN6200, and Expiration date: Unknown), via an unspecified route of administration, administered in upper left arm on 23Feb2021 09:00 (at the age of 77-year-old) as dose 2, single for COVID-19 immunization. The patient medical history included vertigo. Concomitant medications included losartan (LOSARTAN), alprazolam (ALPRAZOLAM), and simvastatin (SIMVASTATIN). The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: EL9262, and Expiration date: Unknown), via an unspecified route of administration, administered in upper left arm on 02Feb2021 (at the age of 77-year-old) as dose 1, single for COVID-19 immunization. No investigation assessment. It was reported that, the patient received vaccine on Tuesday morning at 9 o'clock. The patient had normal adverse events from the second shot of the vaccine, first 2 days he had common symptoms which are of little significance, typical symptoms, nothing usual, all within the parameters, on which he got on the following day (24Feb2021, Wednesday) and the symptoms were "basically gone" (like the symptoms had passed, and the patient felt really good) by Thursday (25Feb2021). On Friday (26Feb2021), also he felt great. However, on the same day (on 26Feb2021), he started to develop vertigo-type dizziness with slight headache. The patient reported that "I have vertigo". So, he did his typical vertigo exercises which seemed to have a little impact whatsoever and seem to had a different reaction then he normally do when he get vertigo. The patient classified his headache as mild and his vertigo-type dizziness as severe since it interferes with him when he had to go to the bathroom late at night. The headache was mild, the patient called the doctor's office and spoke to the Nurse practitioner, and she prescribed Meclizine 12.5 mg, one tablet twice daily for the vertigo-type dizziness. So, the patient had taken one a day of those. He said that he did not feel other adverse events like fever or trouble breathing. The patient reported the vertigo-type dizziness was still happening until the day of reporting (28Feb2021). The patient had also been in touch with a pharmacist and the pharmacist reported that he had multiple calls about reports of vertigo-type dizziness with a slight headache. The patient said that his adverse event did not occur immediately after the vaccine was administered but it occurred days after getting the shot. Pharmacist told him that the vertigo-type dizziness that were reported to the pharmacist had a duration of 5-10 days. The patient was sure if the other people have a history of vertigo. The patient was convinced that there was a correlation with his adverse event with the Pfizer COVID-19 vaccine because he had heard multiple reports about this happening with other people. He believed it was an emerging adverse event associated with the vaccine. The patient just wanted to inquire "is that something that you are aware of and have heard about especially when you thought all the side effects were gone and all of a sudden this issue. And it's a typical vertigo". The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.